CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 84% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Histogen Inc. - HSTO CFD

1.3359
4.28%
  • Summary
  • Historical Data
  • Events
  • Ownership
Trading Conditions
Spread 0.0582
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.024068 %
Charges from borrowed part ($-0.96)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.024068%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.001846 %
Charges from borrowed part ($0.07)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
0.001846%
Overnight fee time 21:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 1.3957
Open* 1.3059
1-Year Change* 321.26%
Day's Range* 1.3059 - 1.4156
52 wk Range 0.15-1.23
Average Volume (10 days) N/A
Average Volume (3 months) 64.45M
Market Cap 7.98M
P/E Ratio -100.00K
Shares Outstanding 49.95M
Revenue 1.03M
EPS -0.40
Dividend (Yield %) N/A
Beta 0.96
Next Earnings Date Aug 9, 2022

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Mar 20, 2023 1.3957 0.0997 7.69% 1.2960 1.4256 1.1464
Mar 17, 2023 1.3359 0.2293 20.72% 1.1066 1.5951 1.0467
Mar 16, 2023 0.8203 -0.0754 -8.42% 0.8957 0.8957 0.8025
Mar 15, 2023 0.8797 -0.0046 -0.52% 0.8843 0.8997 0.8672
Mar 14, 2023 0.8997 0.0103 1.16% 0.8894 0.9030 0.8673
Mar 13, 2023 0.8992 -0.0483 -5.10% 0.9475 0.9625 0.8991
Mar 10, 2023 0.9371 0.0200 2.18% 0.9171 0.9371 0.9071
Mar 9, 2023 0.9291 -0.0777 -7.72% 1.0068 1.0168 0.8972
Mar 8, 2023 1.0268 -0.0399 -3.74% 1.0667 1.2262 1.0068
Mar 7, 2023 1.0268 0.1396 15.73% 0.8872 1.0468 0.8872
Mar 6, 2023 0.9073 -0.0098 -1.07% 0.9171 0.9171 0.9006
Mar 3, 2023 0.9072 -0.0399 -4.21% 0.9471 0.9471 0.9071
Mar 2, 2023 0.8972 0.0020 0.22% 0.8952 0.9072 0.8872
Mar 1, 2023 0.9371 -0.0498 -5.05% 0.9869 0.9869 0.9274
Feb 28, 2023 0.9969 0.0234 2.40% 0.9735 1.0068 0.9670
Feb 27, 2023 0.9869 -0.0299 -2.94% 1.0168 1.0368 0.9869
Feb 24, 2023 0.9969 -0.0099 -0.98% 1.0068 1.0168 0.9968
Feb 23, 2023 1.0168 0.0100 0.99% 1.0068 1.0368 1.0068
Feb 22, 2023 1.0268 0.0200 1.99% 1.0068 1.0368 1.0068
Feb 21, 2023 1.0068 -0.0399 -3.81% 1.0467 1.0467 0.9968

Histogen Inc. Events

Time (UTC) Country Event
No events scheduled
View all events

Start a global, multi-asset portfolio with an award-winning platform

Trade now Desktop

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Histogen Inc. Company profile

Histogen Inc., a clinical-stage therapeutics company, focuses on developing therapeutics based upon the products of fibroblast cells grown under simulated embryonic conditions. It offers HST-001, a hair stimulating complex that is in Phase 1b/2a clinical trial for the treatment of androgenic alopecia (hair loss); HST-003, a human extracellular matrix, which is in Phase 1/2 clinical trial to treat articular cartilage defects in the knee; and Emricasan, an orally active pan-caspase inhibitor that is in Phase 1 clinical trial for the treatment of COVID-19. The company''s pre-clinical programs include HST-004, a cell conditioned media (CCM) solution to treat spinal disc repair; and HST-002, a human-derived collagen and extracellular matrix dermal filler for the treatment of facial folds and wrinkles. Histogen Inc. was founded in 2007 and is headquartered in San Diego, California.
Industry: Bio Therapeutic Drugs

10655 Sorrento Valley Road
Suite 200
92121

People also watch

US100

12,655.90 Price
+0.640% 1D Chg, %
Long position overnight fee -0.0241%
Short position overnight fee 0.0018%
Overnight fee time 21:00 (UTC)
Spread 1.8

BTC/USD

28,138.45 Price
+0.130% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 21:00 (UTC)
Spread 60.00

Gold

1,961.72 Price
-0.680% 1D Chg, %
Long position overnight fee -0.0173%
Short position overnight fee 0.0090%
Overnight fee time 21:00 (UTC)
Spread 0.30

XRP/USD

0.43 Price
+9.340% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 21:00 (UTC)
Spread 0.00483

Still looking for a broker you can trust?

Join the 500.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading